Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Linee guida

PDF

Profilassi dell’endocardite batterica

PREVENTION OF BACTERIAL ENDOCARDITIS

FEDERICO MARCHETTI

Pediatra di libera scelta, ASL Lanciano-Vasto (Chieti)

Marzo 1998 - pagg. 185 -187

Abstract
Guidelines for prevention of bacterial endocarditis have been recently revised by the American Heart Association and approved by the American Academy of Pediatrics. The revised guidelines aim at simplifying both eligibility criteria and antibiotic regimens. A cost-benefit analysis should be made for each patient taking into account the risk of bacteremia associated with various procedures and the risk of adverse reactions to drugs. High and moderate risk patients are identified on the basis of the type of cardiac anomaly. Different antibiotic prophylaxis regimens are proposed: amoxycillin is suggested to moderate risk patients for low risk procedures and ampicillin plus gentamicin to high risk patients undergoing high risk procedures. Different options are proposed for patients with allergy to penicillin.

Bibliografia

1. Dajani AS, Taubert KA, Wilson W, et al: Prevention of bacterial endocarditis. JAMA 277, 1794-1801, 1997.
2. Dajani AS, Bisna AL, Chung KJ, et al: Prevention of bacterial endocarditis. JAMA 264, 2919-2922, 1990.
3. Vitiello R, Kaplan EL: La profilassi dell’endocardite batterica. Medico e Bambino 1, 18- 24, 1993.
4. Horstkotte D, Rosin H, Friedrichs W, Loogen F: Contribution for choosing the optimal prophylaxis of bacterial endocarditis. Eur Heart J 8, Suppl, 379-81, 1987.
5. Imperiale TF, Horwitz RI: Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 88, 131-6, 1990.
6. van der Meer JTM, van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF: Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 339, 135-9, 1992.
7. Durack DT: Prevention of infective endocarditis. NEJM 332, 38-44, 1995